WeQual: Eight Exceptional Women Executives Honoured in EMEA Diversity Awards
15.12.2020 18:17:00 EET | Business Wire | Press release
Eight businesswomen holding prominent executive roles in leading companies in Europe, the Middle East and Africa have been named as winners in the annual WeQual Awards (www.wequal.com/awards).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201215005796/en/
WeQual EMEA 2020 - Winners (Photo: Business Wire)
WeQual identifies and recognises world-class women executives, one level below the group C-suite, and is designed to promote diversity and gender equality within the group executive committees of EMEA’s largest companies.
The eight winners were selected from a shortlist of 24 finalists. The successful award holders are employed in Aryzta, Bayer’s Consumer Health Division, Bureau Veritas, Fresenius Medical Care, Ooredoo Qatar, Sodexo, Standard Chartered Bank and Unilever.
Katie Litchfield, Founder and CEO of WeQual, says: “WeQual identifies already successful senior women who are qualified to be appointed to the group C-suite. Our mission is to tackle the slow progress in appointing diverse women to executive roles and highlight successes where they occur.
“The glass-ceiling concept has been an issue for decades, and the drop-off is steepest just below the group C-suite, so it is important to champion gender equality at the top.”
The awards come at an important time for women in business. The global Covid-19 pandemic is in danger of pushing back opportunities for women to be appointed to the most senior positions. “The fact that we are able to celebrate the achievements of these women in major companies at this time sets a shining example to others,” says Katie Litchfield.
The winners are:
− Bola Adesola: Senior Vice-Chairman, Africa, Standard Chartered Bank, Nigeria. Head of Region Category.
− Dr Cora Koppe-Stahrenberg: Executive Vice President, Global Head of Human Resources, Fresenius Medical Care, Germany. People Excellence Category.
− Munera AL-Dosari: Chief Strategy Officer, Ooredoo Qatar. Strategy Development Category.
− Patricia Amaro: Digital Hub and E-commerce Director, Unilever, Spain. Digital Impact Category.
− Patricia Corsi: Global Chief Marketing and Digital Officer, Bayer’s Consumer Health Division, Switzerland. Brand Innovation Category.
− Nathalie Pousin: Chief Financial Officer, France, Africa, GSIT, Bureau Veritas, France. Finance Category.
− Petra Melander: EMEA Account Director, Sodexo, Finland. Commercial Performance Category.
− Rebeca Navarro: Chief Transformation Officer for Europe and Head of Procurement, Aryzta, Switzerland. Transformational Leadership Category.
The 24 finalists were assessed against seven criteria: Leadership, Cognitive Ability, Integrity, Drive and Resilience, Equality, Knowledge of the Business, and Personal Development. All candidates were assessed blind with no name or company revealed in their application.
To choose the winners, eight executive interviewers held 30-minute interviews with the three finalists in each category before each choosing a category winner. The judges were:
− Sir Ian Cheshire, Chairman, Barclays UK
− Viswas Raghavan, CEO EMEA, J.P. Morgan
− Warren East, CEO, Rolls-Royce
− Dame Inga Beale, Chairperson, Mediclinic
− Chris O'Shea, CEO, Centrica
− Ron Kalifa OBE, Chairman, Network International
− Tamara Box, Managing Partner EME, Reed Smith LLP
− Tulsi Naidu, CEO, Zurich Insurance Company UK
All the 24 award finalists have been given access to a range of WeQual support services and networks designed to help them make the step up to the group executive level. A quarter of WeQual award winners in the UK and USA have since been promoted to the global executive committees of FTSE and Fortune 500 companies. There are now 96 senior women involved with WeQual globally.
(Ends)
Notes to editors
About WeQual
WeQual's mission is to make businesses more inclusive by identifying exceptional women executives and address the gender imbalance across the world's Group Executive Committees. Katie Litchfield, founder and CEO of WeQual Awards, devised the new platform which calls for women senior executives to build their case as to why they deserve to be appointed to the Group Executive Committee.
- LinkedIn: https://www.linkedin.com/company/wequal-awards
- Twitter: https://twitter.com/WeQualGlobal
- YouTube: https://www.youtube.com/channel/UCBpixTLeUsQVjwrivAP9-KA
- Facebook: https://www.facebook.com/WeQualAwards
- Instagram: https://www.instagram.com/wequalglobal
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201215005796/en/
Contact information
Katie Litchfield
katie@wequal.com
Mobile: + 44 7796 147466
UK office: +44 20 3290 3389
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 23:42:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f
Dfns Launches Payouts6.3.2026 22:27:00 EET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 21:23:00 EET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 19:30:00 EET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 15:00:00 EET | Press release
Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end workflows spanning onboarding, KYC, AML, fraud, underwriting, payments, disputes, servicing, and collections. For
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom